For instance, the reliance of Pkd1 null cells/cystic tissues on glucose for growth and proliferation has led to the use of 2-deoxyglucose as a novel experimental treatment in ADPKD [41,42,43]. Here, PKD1 is linked to autosomal dominant polycystic kidney disease.